DNMT3A and acute myeloid leukemia: To test our hypothesis, we first identified CHIP-specific 2348 differentially methylated regions (DMRs) by using acute myeloid leukemia patients carrying DNMT3A CHIP mutations (Supplementary Table 8, see Methods)42.